Integra Lifesciences (NQ: IART )
67.45 USD -3.46 (-4.88%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2021 Add to My Watchlist
All news about Integra Lifesciences
Integra Lifesciences Earns IBD Rating Upgrade
November 26, 2019
Integra Lifesciences shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Integra LifeSciences to participate in the Piper Jaffray 31st Annual Healthcare Conference
November 25, 2019
In the latest look at stocks ordered by largest market capitalization, Russell 3000 component Integra LifeSciences Holdings Corp (IART) was identified as having a larger market cap than the smaller end...
From Market News Video
Integra LifeSciences to participate in the 28th Annual Credit Suisse Healthcare Conference
November 06, 2019
Integra Lifesciences Getting Closer To Key Technical Benchmark
November 04, 2019
A Relative Strength Rating upgrade for Integra Lifesciences shows improving technical performance. Will it continue?
Add Up The Pieces: IWR Could Be Worth $62
October 25, 2019
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
From ETF Channel
From Motley Fool
Medtech Giant Unveils Accounting Probe And Sacrifices Its Flat Base
October 24, 2019
Baxter stock plunged to a four-month low in heavy volume Thursday after the medical technology firm announced an accounting investigation that overshadowed a relatively strong third quarter.
The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict
October 20, 2019
Biotech stocks saw some strength last week. Positive clinical readouts, a couple of M&A deals and hopes of drug companies clinching ...
Integra Lifesciences is near a possible buy zone ahead of its earnings report expected around Oct. 24 .
Earnings Season Preview: Integra Lifesciences Near Buy Zone With Quarterly Report Due
October 10, 2019
Integra Lifesciences is working on a base and near a possible buy range ahead of its earnings report expected around Oct. 24 .
Integra LifeSciences to Host Third Quarter 2019 Earnings Results Conference Call on October 24, 2019
October 09, 2019
Integra LifeSciences Presents Cadence® Total Ankle System Retrospective Study Abstract at AOFAS
September 18, 2019
Integra LifeSciences Acquires Rebound Therapeutics Corporation
September 09, 2019
SmarTrend identified an Uptrend for Integra Lifescie (NASDAQ:IART) on June 13th, 2019 at $50.67. In approximately 3 months, Integra Lifescie has returned 15.66% as of today's recent price of...
Integra LifeSciences to participate in the Wells Fargo 2019 Healthcare Conference and the Morgan Stanley 17th Annual Global Healthcare Conference in September 2019
August 21, 2019
SmarTrend identified an Uptrend for Integra Lifescie (NASDAQ:IART) on June 13th, 2019 at $50.67. In approximately 2 months, Integra Lifescie has returned 25.23% as of today's recent price of...
Integra LifeSciences Acquires Arkis Biosciences Inc.
July 29, 2019
SmarTrend identified an Uptrend for Integra Lifescie (NASDAQ:IART) on June 13th, 2019 at $50.67. In approximately 1 month, Integra Lifescie has returned 24.62% as of today's recent price of...
50 Biggest Movers From Yesterday
July 25, 2019
Gainers SigmaTron International, Inc. (NASDAQ: SGMA) shares gained 40.8% to close at $3.73 on Wednesday after the company ...
38 Stocks Moving In Wednesday's Mid-Day Session
July 24, 2019
Gainers Emmaus Life Sciences, Inc. (NASDAQ: EMMA) jumped 33.1% to $5.65. SigmaTron International, Inc. (NASDAQ: SGMA) shares ...
From Motley Fool
The Daily Biotech Pulse: Jounce Jumps On Licensing Deal, Regulus Hit With Partial Clinical Hold, Genomic Health Added to S&P SmallCap Index
July 24, 2019
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting ...
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the second quarter ending June 30, 2019.
The Week Ahead In Biotech: Pharma Earnings Pick Up Pace
July 20, 2019
Biotech stocks had a relatively muted performance last week.Johnson & Johnson (NYSE: JNJ) kick started the second-quarter ...
Integra LifeSciences to Host Second Quarter 2019 Earnings Results Conference Call on July 24, 2019
July 10, 2019
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release second quarter 2019 financial results on Wednesday, July 24, 2019, prior to market...
"Integra LifeSciences partners with Tissue Analytics to advance data analytics in wound care clinical trials"
July 08, 2019
Integra LifeSciences, a leading global medical technology company, is pleased to announce a pioneering partnership with Tissue Analytics, an AI-powered software solution for wound assessment and...
From PR Newswire
Integra LifeSciences Announces Promotion of Glenn Coleman to Newly-Created Role of Chief Operating Officer and Appointment of Carrie Anderson as Chief Financial Officer
June 24, 2019
Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today announced the promotion of Glenn Coleman to the newly-created role of chief operating...